The many research projects currently underway for macular degeneration, diabetic eye disease, glaucoma, and dry eye disease rapidly impact EFEI patients’ treatments and outcomes.  Our doctors have witnessed the difference these advances can make for patients, and they strive to apply the knowledge they gain through their research to the needs of our patients every day.  By combining state-of-the-art diagnostic equipment, with the latest clinical advances, our patients receive cutting edge treatments, which are customized for their individual situations.


The contributions of the Doctors at EFEI to the treatment of Wet Macular Degeneration and Glaucoma have been featured in the leading European Ophthalmology Journal—Euro Times, on the Macular Degeneration website: Med Page TodayMD Support , as well as on the internationally recognized medical research website Doctor’s Guide , where research was ranked as a key contribution of the year.  In addition, the EFEI doctors have taught their findings to doctors from around the world at the annual meetings of the Association for Research in Vision and Ophthalmology, the American Academy of Ophthalmology, and the Asia-Pacific Academy of Ophthalmology.


Patients who participate in a clinical trial receive study treatment at no cost, and may be compensated for their time and travel.


Contact a study coordinator directly at